샘플 요청 목록

 카트 문의
시장보고서
상품코드
1594925

수의 종양학 시장

Veterinary Oncology
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수의 종양학 세계 시장은 2030년까지 7억 2,780만 달러에 달할 것으로 전망

2023년 3억 5,820만 달러로 추정되는 수의 종양학 세계 시장은 2023-2030년의 분석 기간 동안 연평균 10.7% 성장하여 2030년에는 7억 2,780만 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 화학요법은 CAGR 11.8%를 기록하여 분석 기간 종료 시점에 2억 4,600만 달러에 달할 것으로 예상됩니다. 방사선 분야의 성장률은 분석 기간 동안 CAGR 9.4%로 추정됩니다.

미국 시장은 9,340만 달러로 추정, 중국은 CAGR 14.0%로 성장할 것으로 예상

미국 수의 종양학 시장은 2023년 9,340만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 시장 규모가 1억 6,800만 달러에 달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 14.0%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 7.2%와 8.8%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 약 8.3%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 수의 종양학 시장 - 주요 동향 및 촉진요인 정리

수의 종양학이란 무엇이며, 왜 동물의료에서 매우 중요한가?

수의 종양학은 동물의 암 진단, 치료 및 관리에 초점을 맞춘 수의학 전문 분야입니다. 화학요법, 방사선요법, 면역요법, 수술, 표적치료 등 다양한 치료법이 있으며, 반려동물과 가축, 심지어 이국적인 동물의 림프종, 비만세포종, 골육종, 흑색종 등 다양한 유형의 암을 치료하기 위해 고안된 치료법들이 있습니다. 수의 종양학은 조기 진단, 고급 치료 옵션 및 지속적인 치료를 통해 동물의 수명을 연장하고 통증을 완화하며 암 환자의 삶의 질을 향상시키는 것을 목표로 합니다.

수의 종양학의 중요성은 개와 고양이와 같은 반려동물뿐만 아니라 가축과 야생동물에서 증가하는 암 유병률에 대응하고 동물에게 종합적인 암 치료를 제공할 수 있는 능력에 있습니다. 건강 관리, 영양 및 생활 환경의 개선으로 반려동물의 수명이 길어지면서 암과 같은 노화 관련 질병이 점점 더 흔해지고 있습니다. 수의 종양학은 전문적인 진단 도구, 맞춤형 치료 계획 및 완화 치료를 제공하여 반려동물 보호자가 복잡한 암 사례를 보다 효과적으로 관리할 수 있도록 돕습니다. 동물 복지와 보호자와 동물 사이의 정서적 유대감에 대한 인식이 높아짐에 따라 동물 종양학은 동물에 대한 더 높은 수준의 배려를 추구하는 광범위한 추세와 일치하며 현대 수의학에 필수적인 요소로 자리 잡고 있습니다.

기술의 발전은 수의 종양학 시장을 어떻게 형성하고 있는가?

기술의 발전은 수의 종양학의 진단, 치료 및 완화 능력을 크게 향상시켜 이 분야 전반의 기술 혁신을 촉진하고 있습니다. 주요 발전 중 하나는 컴퓨터 단층촬영(CT), 자기공명영상(MRI), 양전자방사선단층촬영(PET), 초음파 등 첨단 영상진단 기술의 등장입니다. 이러한 영상진단은 종양의 크기, 위치, 진행 정도에 대한 상세한 정보를 제공하여 수의사가 암을 정확하게 진단하고, 치료 계획을 세우고, 반응을 모니터링할 수 있도록 돕습니다. 또한, 영상 유도 생검과 수술의 정확도가 향상되어 조직 손상을 최소화하고 성공적인 종양 제거 가능성을 높이고 있습니다.

표적치료와 면역치료의 발전은 동물의 암 치료에 새로운 대안을 제시하며 수의 종양학을 변화시켰습니다. 표적 치료는 건강한 조직에 영향을 미치지 않고 특정 암세포를 공격하도록 설계된 약물을 사용하여 효능을 향상시키고 부작용을 줄입니다. 티로신 키나아제 억제제(TKI)와 단일 클론 항체는 특히 비만세포종이나 림프종과 같은 증상에 대해 수의 종양학에서 점점 더 많이 사용되고 있는 표적 치료의 한 예입니다. 동물의 면역체계를 자극하여 암세포를 인식하고 파괴하도록 하는 면역요법도 다양한 유형의 종양에 대한 유망한 치료법으로 떠오르고 있습니다. 개 흑색종 백신과 같은 백신은 공격성이 높은 암 치료에 면역 요법을 사용하는 데 있어 큰 돌파구가 될 수 있습니다.

유전자 검사 및 분자진단을 포함한 정밀의료의 도입으로 수의사는 보다 맞춤화된 치료 계획을 수립할 수 있게 되었습니다. 종양의 유전적 구성을 분석함으로써 수의 암 전문의는 치료 결정의 지침이 되는 특정 돌연변이를 찾아내어 치료 효과를 높이고 생존율을 높일 수 있습니다. 방사선 치료의 통합도 발전하고 있으며, 정위적 방사선 치료(SRT)와 강도조절 방사선 치료(IMRT)가 사용되어 주변 건강한 조직에 대한 손상을 최소화하는 고선량 표적 치료를 제공합니다. 이러한 기술 혁신은 수의 종양학에서 사용할 수 있는 치료 옵션을 넓힐 뿐만 아니라, 동물에게 보다 개인화되고 정확하며 효과적인 암 치료를 제공하기 위한 보다 광범위한 추세와도 일치합니다.

다양한 동물 종에 대한 수의 종양학의 새로운 적용 사례는 무엇인가?

수의 종양학은 반려동물과 비반려동물 모두에서 전문적인 암 치료의 필요성으로 인해 다양한 동물종에서 그 용도가 확대되고 있습니다. 개와 고양이와 같은 반려동물에서는 림프종, 비만세포종, 골육종, 유선종양 등에 종양학 치료가 일반적으로 사용되고 있습니다. 화학요법은 여전히 널리 사용되는 치료법이며, 암의 유형과 병기에 따라 수술이나 방사선 치료와 병행하는 경우가 많습니다. 소동수처리에서는 복강경 종양 절제술과 같은 최소 침습적 수술 기법의 사용도 증가하고 있어 회복 기간이 단축되고 치료 성적도 향상되고 있습니다.

말과 가축을 포함한 대동물에서는 편평상피암, 유육종, 림프종 등의 질병 관리에 수의 종양학이 적용됩니다. 해부학적, 생리적 차이에 따라 치료법은 다르지만, 방사선이나 냉동 수술과 같은 첨단 치료법이 말의 종양 치료에 채택되어 생존율과 삶의 질을 향상시키고 있습니다. 대동물에 맞게 조정된 화학 요법 프로토콜은 지지 요법과 결합되어 가축, 특히 귀중한 번식 동물에 영향을 미치는 특정 유형의 암을 관리하기 위한 수의 종양학 관행의 일부이기도 합니다.

동물원 동물, 조류, 파충류 및 기타 동물원 동물과 야생동물에서 수의 종양학은 동물원 동물, 조류, 파충류 및 인간이 관리하는 다른 종의 암을 관리하는 데 필수적인 분야입니다. 이들 동물은 해부학적 구조, 행동 및 면역 반응의 차이로 인해 암 치료에 있어 독특한 과제를 가지고 있으며, 전문적인 진단 및 치료 접근법이 필요합니다. 예를 들어, 전기화학요법(화학요법과 전기 펄스의 조합)과 같은 혁신적인 접근법은 소형 포유류와 이국적인 반려동물의 종양 치료에 사용되어 효과적이고 최소 침습적인 치료 옵션을 제공합니다. 다양한 동물종에서 수의 종양학의 적용이 확대되고 있는 것은 동물 건강관리의 발전과 암 동물의 예후 개선에 있어 수의 종양학이 중요한 역할을 하고 있음을 입증합니다.

수의 종양학 시장의 성장 촉진요인은 무엇인가?

수의 종양학 시장의 성장은 반려동물 사육 증가, 반려동물 건강에 대한 인식 증가, 암 치료 기술의 발전 등 여러 가지 요인에 기인합니다. 주요 성장 요인 중 하나는 반려동물을 가족의 일원으로 여기고 고도의 건강 관리를 원하는 가정이 증가함에 따라 전 세계적으로 반려동물을 기르는 인구가 증가하고 있다는 점입니다. 반려동물의 평균 수명이 늘어남에 따라 반려동물의 암 발생률도 증가하여 전문 종양학 서비스에 대한 수요가 증가하고 있습니다. 진단, 치료, 완화 지원 등의 종합적인 암 치료에 투자하려는 반려동물 보호자들의 의지가 수의 종양학 서비스에 대한 수요를 촉진하고 있습니다.

암 증상에 대한 인식이 높아지고 첨단 진단 도구의 가용성이 높아진 것도 시장 성장에 기여하고 있습니다. 수의사들이 암을 조기에 발견할 수 있게 됨에 따라 보다 효과적인 치료 계획과 예후 개선이 가능해졌습니다. 종양학 전문 서비스를 제공하는 동물병원 및 클리닉 증가와 동물병원 의뢰 센터 증가로 반려동물의 암 치료에 대한 접근성이 향상되고 있습니다. 또한, 수의 종양학에서 원격의료의 활용은 전문 종양 전문의의 활동 범위를 넓혀 원격 진료, 치료 계획 및 후속 치료를 가능하게 하여 의료 서비스가 부족한 지역에서 전문적 치료에 대한 접근성을 향상시키고 있습니다.

표적치료, 정밀의료, 최소침습수술과 같은 기술의 발전은 수의 종양학에서 사용할 수 있는 치료법의 선택의 폭을 크게 넓혀 성공률을 높이고 부작용을 줄였습니다. 수의학 암 연구에 대한 규제 당국의 지원과 자금 지원도 신약과 치료법 개발에 기여하며 이 분야의 기술 혁신을 촉진하고 있습니다. 고품질 동물 헬스케어에 대한 수요가 지속적으로 증가하는 가운데, 반려동물의 건강 증진, 암 치료에 대한 인식 개선, 암 환자의 개별적 치료에 대한 관심 증가 등 세계 트렌드에 힘입어 수의 종양학 시장은 견조한 성장이 예상되고 있습니다.

부문

치료법(화학요법, 방사선요법, 면역요법, 수술, 기타 치료법), 암 유형(림프종, 비만세포암, 유방암, 편평상피암, 기타 암 유형), 동물의 유형(개, 고양이)

조사 대상 기업 예시(총 42건)

  • Accuray, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health
  • Elekta AB
  • Karyopharm Therapeutics, Inc.
  • Merck Animal Health
  • Torigen Pharmaceuticals
  • Varian
  • Virbac SA
  • Vivesto AB

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.12.02

Global Veterinary Oncology Market to Reach US$727.8 Million by 2030

The global market for Veterinary Oncology estimated at US$358.2 Million in the year 2023, is expected to reach US$727.8 Million by 2030, growing at a CAGR of 10.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$246.0 Million by the end of the analysis period. Growth in the Radiology segment is estimated at 9.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$93.4 Million While China is Forecast to Grow at 14.0% CAGR

The Veterinary Oncology market in the U.S. is estimated at US$93.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$168.0 Million by the year 2030 trailing a CAGR of 14.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Veterinary Oncology Market - Key Trends & Drivers Summarized

What Is Veterinary Oncology, and Why Is It So Crucial in Animal Healthcare?

Veterinary Oncology is a specialized field of veterinary medicine focused on diagnosing, treating, and managing cancer in animals. It encompasses various treatment modalities such as chemotherapy, radiation therapy, immunotherapy, surgery, and targeted therapy, designed to treat different types of cancers, including lymphomas, mast cell tumors, osteosarcomas, and melanomas in pets, livestock, and even exotic animals. Veterinary oncology aims to extend the lifespan of animals, alleviate pain, and improve the quality of life for cancer patients through early diagnosis, advanced treatment options, and ongoing care.

The importance of veterinary oncology lies in its ability to provide comprehensive cancer care for animals, addressing an increasing prevalence of cancer among companion animals such as dogs and cats, as well as livestock and wildlife. As pets are living longer due to improved healthcare, nutrition, and living conditions, age-related conditions like cancer have become more common. Veterinary oncology offers specialized diagnostic tools, personalized treatment plans, and palliative care, helping pet owners manage complex cancer cases more effectively. With growing awareness of animal welfare and the emotional bond between pet owners and their animals, veterinary oncology has become a vital component of modern veterinary medicine, aligning with broader trends toward more advanced and compassionate care for animals.

How Are Technological Advancements Shaping the Veterinary Oncology Market?

Technological advancements have significantly enhanced the diagnostic, therapeutic, and palliative capabilities of Veterinary Oncology, driving innovation across the field. One of the major developments is the rise of advanced diagnostic imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. These imaging modalities provide detailed insights into tumor size, location, and progression, enabling veterinarians to accurately diagnose cancer, plan treatments, and monitor responses. Imaging-guided biopsies and surgeries have also improved precision, minimizing tissue damage and increasing the likelihood of successful tumor removal.

Advancements in targeted therapies and immunotherapies have transformed veterinary oncology, offering new options for treating cancers in animals. Targeted therapies use drugs designed to attack specific cancer cells without affecting healthy tissues, improving efficacy and reducing side effects. Tyrosine kinase inhibitors (TKIs) and monoclonal antibodies are examples of targeted treatments that are increasingly being used in veterinary oncology, especially for conditions like mast cell tumors and lymphomas. Immunotherapies, which stimulate the animal’s immune system to recognize and destroy cancer cells, are also emerging as promising treatments for various types of tumors in animals. Vaccines, such as the melanoma vaccine for dogs, represent a significant breakthrough in using immunotherapy to manage aggressive cancers.

The adoption of precision medicine, including genetic testing and molecular diagnostics, has enabled veterinarians to develop more personalized treatment plans. By analyzing the genetic makeup of tumors, veterinary oncologists can identify specific mutations that guide treatment decisions, increasing the effectiveness of therapies and improving survival rates. The integration of radiation therapy has also advanced, with the use of stereotactic radiation therapy (SRT) and intensity-modulated radiation therapy (IMRT), offering high-dose, targeted treatments that minimize damage to surrounding healthy tissues. These technological innovations not only expand the treatment options available in veterinary oncology but also align with broader trends toward more personalized, precise, and effective cancer care for animals.

What Are the Emerging Applications of Veterinary Oncology Across Different Animal Types?

Veterinary Oncology is finding expanding applications across a variety of animal species, driven by the need for specialized cancer care in both companion and non-companion animals. In companion animals, such as dogs and cats, oncology treatments are commonly used for lymphomas, mast cell tumors, osteosarcomas, and mammary gland tumors. Chemotherapy remains a widely used treatment option, often in combination with surgery or radiation therapy, depending on the type and stage of the cancer. The use of less invasive surgical techniques, such as laparoscopic tumor removal, has also increased in treating small animals, offering quicker recovery times and improved outcomes.

In large animals, including horses and livestock, veterinary oncology is applied to manage conditions such as squamous cell carcinoma, sarcoids, and lymphoma. While the treatment options may differ due to anatomical and physiological variations, advanced therapies like radiation and cryosurgery are employed to treat tumors in horses, improving survival rates and quality of life. Chemotherapy protocols tailored for large animals, combined with supportive care, are also part of veterinary oncology practice for managing certain types of cancers in livestock, particularly those affecting valuable breeding animals.

In exotic animals and wildlife, veterinary oncology has become essential for managing cancers in zoo animals, birds, reptiles, and other species under human care. These animals present unique challenges in cancer treatment due to differences in anatomy, behavior, and immune response, requiring specialized diagnostic and therapeutic approaches. For example, innovative approaches like electrochemotherapy (a combination of chemotherapy and electrical pulses) are used to treat tumors in small mammals and exotic pets, offering an effective and minimally invasive option. The expanding applications of veterinary oncology across diverse animal types underscore its critical role in advancing animal healthcare and improving outcomes for animals with cancer.

What Drives Growth in the Veterinary Oncology Market?

The growth in the Veterinary Oncology market is driven by several factors, including increasing pet ownership, rising awareness of pet health, and advancements in cancer treatment technologies. One of the primary growth drivers is the global rise in pet ownership, with more households viewing pets as family members and seeking advanced healthcare options for them. As the average lifespan of pets increases, the incidence of cancer among companion animals has also risen, creating greater demand for specialized oncology services. Pet owners’ willingness to invest in comprehensive cancer care, including diagnostics, treatment, and palliative support, has fueled the demand for veterinary oncology services.

The growing awareness of cancer symptoms and the availability of advanced diagnostic tools have also contributed to market growth. Veterinarians are now able to detect cancers earlier, allowing for more effective treatment plans and better prognoses. The increasing number of veterinary clinics and hospitals offering specialized oncology services, coupled with the rise of veterinary referral centers, has improved access to cancer care for pets. Additionally, the use of telemedicine in veterinary oncology has expanded the reach of expert oncologists, enabling remote consultations, treatment planning, and follow-up care, which enhances access to specialized treatments in underserved areas.

Technological advancements, including targeted therapies, precision medicine, and minimally invasive procedures, have significantly expanded the treatment options available in veterinary oncology, improving success rates and reducing side effects. Regulatory support and funding for veterinary cancer research have also contributed to the development of new drugs and treatments, driving innovation in the field. As the demand for high-quality animal healthcare continues to grow, the Veterinary Oncology market is poised for robust expansion, supported by global trends toward better pet health, increasing awareness of cancer treatments, and a growing focus on personalized care for animals with cancer.

SCOPE OF STUDY:

The report analyzes the Veterinary Oncology market in terms of US$ Thousand by the following Animal Type; Cancer Type; Therapy, and Geographic Regions/Countries:

Segments:

Therapy (Chemotherapy, Radiology, Immunotherapy, Surgery, Other Therapies); Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Other Cancer Types); Animal Type (Canine, Feline)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Accuray, Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health
  • Elekta AB
  • Karyopharm Therapeutics, Inc.
  • Merck Animal Health
  • Torigen Pharmaceuticals
  • Varian
  • Virbac SA
  • Vivesto AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Veterinary Oncology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer in Animals Drives Veterinary Oncology Market
    • Expanding Use of Chemotherapy Sets the Stage for Oncology Market Expansion
    • Case Overview: Demand for Immunotherapy Enhances Veterinary Oncology Market
    • Innovations in Tumor-Specific Diagnostics Generate New Opportunities
    • Growing Use of Radiation Therapy Sustains Veterinary Oncology Demand
    • Push for Early Cancer Detection Drives Oncology Market
    • Expanding Use of Monoclonal Antibodies Drives Veterinary Oncology Demand
    • Focus on Quality of Life in Pets Bodes Well for Veterinary Oncology
    • Innovations in Drug Delivery Systems Propel Veterinary Oncology Market
    • Increasing Use of Biomarkers in Diagnosis Drives Oncology Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Veterinary Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Canine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Canine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Canine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Feline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Mast Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Mast Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Mast Cell Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Mammary & Squamous Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Mammary & Squamous Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Mammary & Squamous Cell Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 36: World 16-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 37: World Veterinary Oncology Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • CHINA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Veterinary Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Veterinary Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • INDIA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Veterinary Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Veterinary Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030
  • AFRICA
    • Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제